The Effect of UV-Irradiation on Cutaneous Cicatrices

This study has been completed.
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00261963
First received: December 2, 2005
Last updated: June 4, 2007
Last verified: June 2007
  Purpose

The purpose of this study is to examine the effect of UV-irradiation on human cutaneous cicatrices by clinical examinations and histological, immunohistochemical and biochemical analyses.


Condition Intervention
Skin Cicatrices
Device: ultraviolet light

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Prevention
Official Title: The Effect of UV-Irradiation on Cutaneous Cicatrices -A Randomised, Controlled Study With Clinical, Skin Reflectance, Histological and Biochemical Evaluations

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Estimated Enrollment: 15
Study Start Date: February 2004
Estimated Study Completion Date: August 2006
  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Non-smoking volunteers,
  • Skintypes II or III

Exclusion Criteria:

  • Atopic dermatitis,
  • Tendency to produce keloids or hypertrophic scars,
  • Exposure of UV light during the last 3 months,
  • Medical treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00261963

Locations
Denmark
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Eva Due, MD Bispebjerg Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00261963     History of Changes
Other Study ID Numbers: KF 01-187-03
Study First Received: December 2, 2005
Last Updated: June 4, 2007
Health Authority: Denmark: The Ministry of the Interior and Health

Additional relevant MeSH terms:
Cicatrix
Fibrosis
Pathologic Processes

ClinicalTrials.gov processed this record on September 22, 2014